Information

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm

Key Opinions in Medicine

  • Register
  • Login
Skip to content
  • Home
  • Issues
    • Allergy & Immunology
    • Cardiology
    • Conference
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology
    • Haematology
    • Hepatology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Nursing
    • Obstetrics & Gynaecology
    • Oncology
    • Psychiatry
    • Rheumatology
    • Surgery Insights
    • Urology
  • About
  • Contact
  • Register
  • Login

Haematology

Back to Issues
What impact might real-world evidence have on the management of haematological conditions in the UK?

What impact might real-world evidence have on the management of haematological conditions in the UK?

The volume and diversity of real-world data have been growing exponentially as technology and integrated electronic medical records, and patient and physician surveys, have made this information...

The role of gilteritinib (XOSPATA™▼) in treating adults with relapsed/refractory FLT3+ acute myeloid leukaemia (AML)

The role of gilteritinib (XOSPATA™▼) in treating adults with relapsed/refractory FLT3+ acute myeloid leukaemia (AML)

Acquired activating mutations in the FMS-like tyrosine kinase 3 (FLT3) gene occur in approximately 30% of adults with AML and FLT3 internal tandem duplications (ITDs) are associated with particularly...

Reaching peaks, raising troughs: Maximizing protection to achieve patient aspirations

Reaching peaks, raising troughs: Maximizing protection to achieve patient aspirations

The World Federation of Hemophilia (WFH) 2018 World Congress: Bayer Satellite Symposium   The XXXIII WFH World Congress took place in Glasgow, UK, on 20–24 May 2018.1  Founded by the World...

Unmet needs in newly diagnosed multiple myeloma

Unmet needs in newly diagnosed multiple myeloma

Multiple myeloma (MM) is an incurable haematological malignancy characterised by aberrant clonal proliferation of plasma cells. Multiple mutations concurrently deregulate the biological functioning...

Secondary Immunodeficiency

Secondary Immunodeficiency

Intravenous immunoglobulin (IVIG) can influence the immune system via multiple mechanisms including neutralisation of pathogens and anti-inflammatory effects. Its therapeutic role has expanded...

Implications of ECIL-6 for clinicians

Implications of ECIL-6 for clinicians

During the 2017 12th Annual Fungal Update, held in the Great Hall at St Bartholomew’s Hospital, London, on February 4th, experts reviewed new evidence on the growing threat of antifungal resistance...

Latest evidence on fungal infections

Latest evidence on fungal infections

3rd & 4th February 2017, St Bartholomew’s Hospital, London Dr Samir Agrawal, Chair of the Organising Committee, welcomed participants to the 12th Annual Fungal Update in the Great Hall at St...

Invasive aspergillosis and mucormycosis

Invasive aspergillosis and mucormycosis

Isavuconazole (Cresemba®), a triazole antifungal, authorised in the EU since October 2015, demonstrated clinical effectiveness in pivotal trials of invasive aspergillosis and mucormycosis, and a...

In pursuit of long-term disease control in multiple myeloma

In pursuit of long-term disease control in multiple myeloma

Multiple myeloma (MM) is a heterogeneous disease for which, despite the continuing advances in existing therapies such as the immunomodulatory drugs (IMiDs) and proteasome inhibitors (PIs), there is...

Second Spring Forum Haemophilia 2015

Second Spring Forum Haemophilia 2015

The 2nd Spring Forum Haemophilia 2015 – ‘New Avenues in Human rFVIII Replacement: Perspectives and Challenges for the Years Ahead’– was held in Berlin, Germany, on 17 and 18 April 2015. The...

1 2 3

Search Issues

RSS Feeds

  • All issues
  • Haematology issues

Specialties

Click below to filter the KOM articles by specialty.

  • Allergy & Immunology
  • Cardiology
  • Conference
  • Critical Care
  • Dentistry
  • Dermatology
  • Diabetes & Endocrinology
  • Gastroenterology
  • Haematology
  • Hepatology
  • Infectious Diseases
  • Metabolic Disorders
  • Neurology
  • Nursing
  • Obstetrics & Gynaecology
  • Oncology
  • Psychiatry
  • Rheumatology
  • Surgery Insights
  • Urology

Popular Issues

Konkurrenz für den Therapiestandard

Grüntee-Extrakt bei anogenitalen Feigwarzen

Register

Register

Sign up for free access to Wiley’s Key Opinions in Medicine to keep up to date with latest trends and key developments within your specialty area.

Share

Copyright © 2000-2021 by John Wiley & Sons, Inc., or related companies. All rights reserved.
Review our privacy policy. .
Web design and marketing agency Leamington Spa